Charles River Laboratories Intl. Inc vs Pinterest Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $301.79 (market cap $14.23B), while Pinterest Inc trades at $21.4 (market cap $11.63B). The key difference: Charles River Laboratories Intl. Inc is the larger of the two by market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Pinterest Inc for 85 Days on average.
| CRL | PINS | |
|---|---|---|
Market Cap | $14.23B | $11.63B |
Volume | 1,176,885 | 12,792,940 |
Sector | Health | Media |
52-Week High | $310.77 | $35.24 |
52-Week Low | $149.93 | $15.42 |
Typical Hold Time | 33 Days | 85 Days |
Enterprise Value | $17.06B | $11.55B |
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $298, down 0.77% on the day, with strong analyst support showing 73% buy ratings and a $305.50 consensus price target. The stock maintains a bullish technical outlook with support at $292 and resistance at $301, while recent earnings have consistently beaten expectations despite negative net income margins. The company's 2026 Investor Day highlighted a strategic vision targeting 5-7% organic growth and $300 million in savings by 2030.
CRL presents a compelling growth story with solid operational cash flow and strategic initiatives, though investors face risks from negative profitability metrics and elevated valuation multiples. The stock's current position near analyst targets suggests limited upside without improved earnings execution, while ongoing margin pressures and debt levels require careful monitoring amid the company's transformation efforts.
Pinterest (PINS) trades at $20.525, up 1.06% today, with a bullish technical signal from moving averages but a bearish oscillator reading. The company reported strong revenue growth to $4.22 billion in 2025, with net income of $416.86 million, and has beaten EPS estimates in recent quarters. Analyst consensus is bullish with a $27.93 price target, though insider selling and negative net cash flow trends present cautionary notes.
The outlook for PINS is positive given its revenue growth trajectory and high gross margins, but valuation multiples like a P/E of 60.38 suggest premium pricing. Risks include reliance on advertising monetization and competitive pressures. Upside potential exists if international monetization accelerates and earnings continue to exceed expectations.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →